Cellcept

In the US, CellCept (mycophenolate mofetil systemic) is a member of the drug class selective immunosuppressants and is used to treat Nephrotic Syndrome and Organ Transplant - Rejection Prophylaxis.

US matches:

• Cellcept


• CellCept Capsules


• CellCept Solution


• CellCept Suspension


• Cellcept Oral

UK matches:

• CellCept 1g/5ml powder for oral suspension (SPC)

Ingredient matches for CellCept

Mycophenolic Acid

Mycophenolic Acid mofetil (a derivative of Mycophenolic Acid) is reported as an ingredient of CellCept in the following countries:

• Algeria


• Argentina


• Aruba


• Australia


• Austria


• Bahrain


• Bangladesh


• Belarus


• Belgium


• Bosnia & Herzegowina


• Botswana


• Brazil


• Canada


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Cuba


• Cyprus


• Czech Republic


• Denmark


• Ecuador


• Egypt


• Estonia


• Finland


• France


• Georgia


• Germany


• Ghana


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Indonesia


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Jamaica


• Japan


• Jordan


• Kazakhstan


• Kenya


• Kuwait


• Lebanon


• Lithuania


• Luxembourg


• Macedonia


• Malawi


• Malaysia


• Mauritius


• Mexico


• Morocco


• Namibia


• Nepal


• Netherlands


• New Zealand


• Nigeria


• Norway


• Oman


• Pakistan


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• South Korea


• Spain


• Sri Lanka


• Sudan


• Sweden


• Switzerland


• Syria


• Taiwan


• Tanzania


• Thailand


• Trinidad & Tobago


• Tunisia


• Turkey


• Uganda


• Ukraine


• United Arab Emirates


• United Kingdom


• United States


• Uruguay


• Uzbekistan


• Venezuela


• Vietnam


• Zambia


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.